English
Published: 2010-01-18 12:00:00 CET
C-Rad AB
Company Announcement
Agreements of strategic importance signed between C-RAD AB and IBA Dosimetry
Pressrelease 2010-01-18

 

C-RAD AB with its three fully owned
subsidiaries are all active in the field of
radiation therapy. The C-RAD group
and IBA Dosimetry have signed agreements
regarding manufacturing, technical
cooperation and sales. 

The subsidiary C-RAD Imaging AB will from 1 January
2010 be responsible for the
manufacturing and the further development of the
IBA diode detector program.
The activities will be located in Uppsala. As a
result the Uppsala operation
will be moved to larger premises. Deliveries to
IBA in 2010 have been
negotiated and agreed upon. The agreement is in the
field of diode detectors
mutually exclusive. 

C-RAD AB will from 1 January
2010 be responsible for sales and service of the
IBA Dosimetry program in
Scandinavia except for Norway. The IBA Dosimetry
products are today being used
at most radiation therapy clinics in Scandinavia
.These activities will be
handled by the  same staff today selling and doing
service for the C-RAD
Sentinel system in the Scandinavian countries. 

To take care of these
activities three persons have been added to the group.

 

Erik Hedlund,
CEO, C-RAD AB:

"We are thrilled to have signed these agreements with the IBA
group. The
cooperation will bring synergies to the present C-RAD activities
in
development, manufacturing and sales. The partnership with IBA is of
strategic
importance.” 

 

Christian Kling, VP Logistics & Production,
IBA Dosimetry:

“With this cooperation IBA Dosimetry is consequently
following its strategic
approach and is strengthening its presence on the
Scandinavian Market. We are
looking forward to a successful and fruitful
cooperation with C-RAD.” 

 

For further information: 

Erik Hedlund,
CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se

 




 

ABOUT  IBA

IBA develops and markets leading edge technologies,
pharmaceuticals and
healthcare with a focus on cancer diagnosis and therapy.
Leveraging on also
active in the field of industrial sterilization and
ionization. Listed on the
pan-European stock exchange Euronext, IBA is
included in the IBAB.BR and
Bloomberg IBAB.BB. 

Website:
http://www.iba-worldwide.com
 


file2.pdf